Do not abruptly discontinue/modify Parkinson’s disease therapy.
According to recent evidence, therapy with anti-Parkinsonian drugs is inappropriately discontinued or modified in a large percentage (up to 75%) of patients with Parkinson’s disease who are admitted to emergency or non-neurological hospital wards. This is one of...
Do not delay prescribing levodopa if appropriate, and instead, do not use drugs for the complicated phase of the disease prematurely.
Levodopa prescription as a drug treatment in Parkinson’s disease is often delayed in favour of other drug categories (such as dopamine agonists) due to concerns about the risk of drug-induced motor complications or levodopa toxicity. However, recent evidence has...
Do not use drugs that may worsen the symptoms of Parkinson’s disease, such as anti-dopaminergic, alphalitic and anticholinergic drugs, without consulting your neurologist.
People with Parkinson’s disease may require medication for other reasons. Their general practitioner should therefore be careful to consider any prescriptions from other specialists for drugs that may worsen certain motor and non-motor symptoms of the disease....
Do not use brain scintigraphic examinations such as brain SPECT (Single Photon Emission Tomography) with dopamine transporter marker (DAT-SCAN) or myocardial examination with Metaiodobenzylguanidine (MIBG) as well as positron emission brain tomography (PET) with any radionuclide, for diagnostic confirmation of Parkinson’s disease or to evaluate its progression.
The finding of a positive brain SPECT (single photon emission tomography) scan with dopamine transporter marker (DAT-SCAN) does not establish a diagnosis of Parkinson’s disease, which is instead based on the presence of clinical elements that meet the current...The campaign DOING MORE DOES NOT MEAN DOING BETTER – CHOOSING WISELY ITALY is promoted by Italy’s Slow Medicine
Recent Comments